FRAXA Research Foundation has awarded a 2017 FRAXA Fellowship to Dr. Elizabeth McCullagh of $90,000 over two years. Dr. McCullagh is a postdoctoral fellow in the lab of Dr. Achem Klug at the University of Colorado at Denver. The team specializes in studying the brain’s sound localization pathway.
Studies have shown that the function of inhibitory networks is disturbed in fragile X. This abnormality is not well understood but appears to be secondary to abnormalities in metabotropic glutamate and endocannabinoid systems. With a $90,000 grant from FRAXA in 2013-2014, Dr. Molly Huntsman’s team examined how these networks interact and how inhibitory deficits can best be remedied.
With a $35,000 grant from FRAXA Research Foundation, Dr. Nicole Tartaglia from the University of Colorado Denver and Tracey Stackhouse aimed to develop neuromotor outcome measures for use in clinical trials in FXS, and to contribute to a deeper understanding of the neuromotor issues involved in FXS. This collaborative project was completed at the two sites of the Colorado Fragile X Clinic: The Children’s Hospital and Developmental FX. Dr. Nicole Tartaglia is the Medical Director of the Fragile X Clinic at The Children’s Hospital of Denver. Tracy Murnan Stackhouse, MA, OTR is the co-founder of the Developmental & Fragile X Resource Centre (Developmental FX), a clinic specializing in fragile X.
With a $49,000 grant from FRAXA Research Foundation in 2003, Dr. Linda Crnic at the University of Colorado continued studies of MPEP in fragile X mice, exploring whether chronic use ameliorates symptoms of Fragile X syndrome without impairing cognitive function.